Back to Rankings

SVRA

SavaraD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
SVRA vs peer average
32/100
SVRA vs. peer average (D vs. C)
Grade spread
A 3 · B 2 · C 1 · D 1 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ANAB is the first available peer comparator.

Small-cap biotech with similar market value; useful mainly as a single-program/event-risk comparator rather than an indication match.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerANABAnaptysBio
SVRA
Savara
ANAB
AnaptysBio
Grade
D
A
Momentum
39
95
Value
41
41
Sentiment
58
53
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs ANAB

SVRA / ANAB
Grade Position
Below peers
SVRA vs. peer average (D vs. C)
32/100
Momentum
39
ANAB
Value
41
SVRA
Sentiment
58
SVRA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SVRA
1
ANAB
ANAB
B
80/100
-2
2
NVAX
NVAX
B
80/100
-2
3
IMTX
IMTX
C
60/100
-1
4
CRON
Cronos Group Inc Common
F
20/100
+1
5
XERS
Xeris Biopharma Holdings Inc Common
A
100/100
-3
ANAB is the first peer returned for this comparison set.